Kalvista Pharmaceuticals, Inc. (KALV) — SC 13D/A Filings

SC 13D/A Filings (4)

• Frazier Life Sciences Adjusts KalVista Stake to 19.9% — Nov 7, 2024 Risk: medium
  Frazier Life Sciences Public Fund, L.P. and its affiliates, including Albert Cha and Daniel Estes, have filed an amendment to their Schedule 13D. This filing re
• TCG Crossover Fund & Chen Yu Amend KalVista Stake — Apr 1, 2024 Risk: medium
  TCG Crossover Fund I, L.P. and Chen Yu have filed an amendment (Amendment No. 2) to their Schedule 13D regarding KalVista Pharmaceuticals, Inc. The filing, date
• Frazier Life Sciences Updates KalVista Pharma Holdings — Feb 22, 2024 Risk: low
  Frazier Life Sciences Public Fund, L.P. and its affiliates, including Frazier Life Sciences X, L.P. and Frazier Life Sciences XI, L.P., filed an SC 13D/A on Feb
• TCG Crossover Amends KalVista Pharmaceuticals Stake — Feb 20, 2024 Risk: low
  TCG Crossover GP I, LLC, along with TCG Crossover Fund I, L.P. and Chen Yu, filed an Amendment No. 1 to their Schedule 13D for KalVista Pharmaceuticals, Inc. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX